What is the latest status of the project “AbbVie Illinois API Manufacturing Plant Expansion”?

The status recorded for “AbbVie Illinois API Manufacturing Plant Expansion” is planned.

What is the budget and commercial profile for the project “AbbVie Illinois API Manufacturing Plant Expansion”?

Taiyo normalizes the budget of “AbbVie Illinois API Manufacturing Plant Expansion” to USD 195000000.

Where can I verify the source and access all details for “AbbVie Illinois API Manufacturing Plant Expansion”?

This Taiyo project page references AInvest along with the original URL (https://www.ainvest.com/news/strategic-reshoring-api-manufacturing-long-term-play-tariff-driven-era-2508/). Taiyo standardizes official data into a consistent, searchable project profile.

AbbVie Illinois API Manufacturing Plant Expansion

Planned · Illinois · Last reported Aug 2025

Source: AInvest

Project

Planned

AbbVie is expanding its North Chicago facility in Illinois with a $195 million investment to bolster domestic production of complex active pharmaceutical ingredients (APIs) for neuroscience, immunology, and oncology therapies. The project includes reactors up to 12,000 liters and advanced crystallization technology, aiming to reduce reliance on offshore suppliers and leverage U.S. manufacturing in

Status: Prospective
Sector: Manufacturing (Industrial)
Location: North Chicago, Illinois, United States of America
Updated: 22 Jul 2026
Source: AInvest

ConstructChat

Ask ConstructChat about AbbVie Illinois API Manufacturing Plant Expansion

Pick a question to edit it, or write your own.

First answer free · no account

I am a

Project Information

4 Q

The project “AbbVie Illinois API Manufacturing Plant Expansion” is an infrastructure initiative in the Manufacturing (Industrial) sector, located in North Chicago, Illinois, United States. Taiyo aggregates data on it from AInvest.

Participants

Not available for this record.

Status

Original status	planned
Taiyo status	Prospective
Taiyo last update	2026-07-22

Contact

Not available for this record.

Description

Description	AbbVie is expanding its North Chicago facility in Illinois with a $195 million investment to bolster domestic production of complex active pharmaceutical ingredients (APIs) for neuroscience, immunology, and oncology therapies. The project includes reactors up to 12,000 liters and advanced crystallization technology, aiming to reduce reliance on offshore suppliers and leverage U.S. manufacturing incentives.
Original sector	Health Care
Budget

Location

Country	United States of America (USA)
State	Illinois
City	North Chicago

Source

Source	AInvest
URL

More Details

Record type	Project
Sector	Manufacturing (Industrial)
Article published date	2025-08-14

Research

Free account

View all details

You are reading the public part. A free account opens the rest:

Every detail on this project
News and media coverage
Technical research

View all details

Free account · no card · lands you back on this project

AbbVie Illinois API Manufacturing Plant Expansion

Ask ConstructChat about AbbVie Illinois API Manufacturing Plant Expansion

Project Information FAQ

Project Information

Research

View all details

More Manufacturing (Industrial) projects in United States